Companies:
53,470
Total Market Cap:
174441609354398.45
Global Rank
#35232
Country Rank
#2006
Market Cap
29.23 M
Price
3.24
Change (%)
2.07%
Volume
11,263
Seoulin Bioscience Co.,Ltd.'s latest marketcap:
29.23 M
As of 08/31/2026, Seoulin Bioscience Co.,Ltd.'s market capitalization has reached $29.23 M. According to our data, Seoulin Bioscience Co.,Ltd. is the 35232th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 29.23 M |
| Revenue (ttm) | 60.76 M |
| Net Income (ttm) | 669,671.67 |
| Shares Out | 9.03 M |
| EPS (ttm) | 0.06 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/29/2025 |
| Earnings Date | 11/13/2026 |
Market Cap Chart
Data Updated: 08/31/2026
Seoulin Bioscience Co.,Ltd.'s yearly market capitalization.
Seoulin Bioscience Co.,Ltd. has seen its market value drop from ₩45.47 B to ₩40.01 B since 2014, representing a total decrease of 12.02% and an annual compound decline rate (CAGR) of 1.09%.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/31/2026 | ₩40.01 B | $29.23 M | -21.45% | 35232 |
| 12/30/2025 | ₩57.46 B | $39.05 M | -6.51% | 28776 |
| 12/30/2024 | ₩61.46 B | $41.18 M | -21.97% | 29334 |
| 12/28/2023 | ₩78.77 B | $60.65 M | -19.25% | 26463 |
| 12/29/2022 | ₩97.55 B | $77.06 M | -44.18% | 23965 |
| 12/30/2021 | ₩174.75 B | $146.79 M | 62.58% | 20664 |
| 12/30/2020 | ₩107.49 B | $0 | 56.83% | 20679 |
| 12/30/2019 | ₩68.54 B | $58.94 M | -9.3% | 20989 |
| 12/28/2018 | ₩75.57 B | $67.25 M | -5.72% | 19376 |
| 12/28/2017 | ₩80.15 B | $74.54 M | -15.91% | 19519 |
Company Profile
About Seoulin Bioscience Co., Ltd.
Seoulin Bioscience Co., Ltd. is a leading bio healthcare company based in South Korea, specializing in innovative solutions for life sciences and healthcare.
Core Offerings
- Bio Research & Production: Advanced solutions supporting bio research and manufacturing processes.
- ecoTree (SLB-120 Instrument): Generates slightly acidic electrolyzed water for applications in the food industry, daily living, and laboratories.
- Plasma-Based Medical Esthetics: Cutting-edge treatments for aesthetic and medical purposes.
- miQ: A diagnostic tool designed for early detection of dementia.
- Functional Cosmetics: Natural fermentation-based skincare and beauty products.
Company Background
Founded in 1984, Seoulin Bioscience Co., Ltd. is headquartered in Seongnam-si, South Korea, and continues to drive advancements in bio healthcare.
Frequently Asked Questions
-
What is Seoulin Bioscience Co.,Ltd.'s (KOSDAQ-038070) current market cap?As of 08/31/2026, Seoulin Bioscience Co.,Ltd. (including the parent company, if applicable) has an estimated market capitalization of $29.23 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Seoulin Bioscience Co.,Ltd. (KOSDAQ-038070) rank globally by market cap?Seoulin Bioscience Co.,Ltd. global market capitalization ranking is approximately 35232 as of 08/31/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.